Elsevier, the information analytics business specialising in science and health, has announced the publication of From Artemisia annua L. to Artemisinins: The Discovery and Development of Artemisinins and Antimalarial Agents by Chinese Nobel laureate Youyou Tu. It is the first book that systematically introduces the origin and development of artemisinine and artemisinine-based drugs. One of the nine new pharmaceutical science books, From Artemisia annua L. to Artemisinins will be a valuable reference work for both researchers involved in the medical industry and scholars who are interested in undertaking innovative research.
From Artemisia annua L. to Artemisinins presents a full view of artemisinin including chemical structure, chemical properties, extracting mode, derivatives, chromogenic reaction, general pharmacological, and toxicology. It features a large amount of experimental data, such as the X-ray crystallography result—the first application reported in China in determining the absolute molecular configuration utilizing the scattering effects of oxygen atoms by X-ray diffraction technique.
Youyou Tu is a Chinese pharmaceutical chemist and educator. She is best known for discovering artemisinin (also known as Qinghaosu) and dihydroartemisinin, which saved millions of lives in the treatment of malaria. Her discovery of artemisinin is regarded as a significant breakthrough of tropical medicine in the 20th century and health improvement for people of tropical developing countries in South Asia, Africa, and South America.
The nine new pharmaceutical sciences titles are:
- From Artemisia annua L. to Artemisinins: The Discovery and Development of Artemisinins and Antimalarial Agents by Youyou Tu;
- Profiles of Drug Substances, Excipients, and Related Methodology, Volume 42, edited by Harry Brittain;
- Essentials of Chinese Materia Medica and Medical Formulas: New Century Traditional Chinese Medicine by Shengyan Xi and Yuewen Gong;
- Adverse Events and Oncotargeted Kinase Inhibitors by Giuseppe Tridente;
- Ion Channels Down Under, edited by Dominic Geraghty and Lachlan Rash;
- Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes, edited by Vijay Mishra, Prashant Kesharwani, Mohd Cairul Mohd Amin and Arun Iyer;
- A Comprehensive and Practical Guide to Clinical Trials, edited by Delva Shamley and Brenda Wright;
- An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology by Padma Nambisan;
- A Paradigm Shift to Prevent and Treat Alzheimer's Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols by Howard Friel and Sally Frautschy.
In order to meet content needs in pharmaceutical sciences, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books will educate the next generation of pharmaceutical scientists, and provide critical foundational content for information professionals.
801 777 223
Your basket